Omar Skalli Selected Research

desmuslin (synemin)

1/2016	Synemin: Molecular Features and the Use of Proximity Ligation Assay to Study Its Interactions.
3/2015	Roles and potential clinical applications of intermediate filament proteins in brain tumors.
1/2014	Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
10/2013	Astrocytoma grade IV (glioblastoma multiforme) displays 3 subtypes with unique expression profiles of intermediate filament proteins.
4/2012	Synemin promotes AKT-dependent glioblastoma cell proliferation by antagonizing PP2A.
9/2008	Intermediate filament protein synemin contributes to the migratory properties of astrocytoma cells by influencing the dynamics of the actin cytoskeleton.
4/2007	Synemin is expressed in reactive astrocytes in neurotrauma and interacts differentially with vimentin and GFAP intermediate filament networks.
9/2006	Synemin expression is widespread in liver fibrosis and is induced in proliferating and malignant biliary epithelial cells.
4/2005	Intermediate filament protein synemin is present in human reactive and malignant astrocytes and associates with ruffled membranes in astrocytoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Omar Skalli Research Topics

Disease

9	Neoplasms (Cancer) 12/2021 - 08/2002
7	Astrocytoma (Pilocytic Astrocytoma) 01/2016 - 08/2002
5	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 08/2002
2	Wounds and Injuries (Trauma) 01/2016 - 11/2010
2	Breast Neoplasms (Breast Cancer) 01/2016 - 08/2002
2	Gliosis 01/2014 - 11/2010
2	Carcinoma (Carcinomatosis) 09/2008 - 09/2006
1	Colitis 12/2021
1	Carcinogenesis 12/2021
1	Dysbiosis 08/2021
1	Cysts 08/2021
1	Chloracne 08/2021
1	Inflammation (Inflammations) 08/2021
1	Body Weight (Weight, Body) 08/2021
1	Brain Neoplasms (Brain Tumor) 03/2015
1	Glioma (Gliomas) 03/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014
1	Alexander Disease (Alexander's Disease) 01/2014
1	Bullous Pemphigoid (Pemphigoid) 02/2013
1	Retinal Detachment (Retinal Detachments) 11/2010
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2009
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2009
1	Hepatocellular Carcinoma (Hepatoma) 09/2006
1	Cholangiocarcinoma 09/2006
1	Hepatitis 09/2006
1	Liver Diseases (Liver Disease) 09/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2006
1	Fatty Liver 09/2006

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2002
9	desmuslin (synemin)IBA 01/2016 - 04/2005
4	VimentinIBA 03/2015 - 04/2007
4	NestinIBA 03/2015 - 04/2007
4	Glial Fibrillary Acidic ProteinIBA 01/2014 - 04/2007
3	Protein Isoforms (Isoforms)IBA 01/2016 - 08/2002
3	ActininIBA 04/2010 - 04/2005
2	Biological ProductsIBA 01/2018 - 10/2013
2	Intermediate Filament ProteinsIBA 03/2015 - 10/2013
1	LipidsIBA 12/2021
1	Ethanol (Ethyl Alcohol)IBA 12/2021
1	AzoxymethaneIBA 12/2021
1	CarcinogensIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Dextran SulfateIBA 12/2021
1	LigandsIBA 08/2021
1	Polychlorinated Dibenzodioxins (TCDD)IBA 08/2021
1	PolymersIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	CateninsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 03/2015
1	Crystallins (Crystallin)IBA 01/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	AntigensIBA 02/2013
1	IntegrinsIBA 02/2013
1	Retinaldehyde (Retinal)IBA 11/2010
1	Peptide Hydrolases (Proteases)FDA Link 06/2009
1	UbiquitinIBA 04/2009
1	VinculinIBA 09/2008
1	PlectinIBA 08/2002
1	Complementary DNA (cDNA)IBA 08/2002
1	Hyaluronic Acid (Hyaluronan)IBA 08/2002
1	EpitopesIBA 08/2002
1	Hyaluronan ReceptorsIBA 08/2002
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2002
1	Monoclonal AntibodiesIBA 08/2002

Therapy/Procedure

1	Therapeutics 03/2015